Xylanase and β-glucanase from Komagataella phaffii DSM 25376 and DSM 26469 (4a28) for all poultry: dose for chickens lowered from 4250/375 to 1400/120 LXU/LGU per kg, colorimetry with wheat arabinoxylan and azo-barley glucan — in the laying hen trials only xylanase was measured

Commission Implementing Regulation (EU) 2025/2556, published on 18 December 2025, authorises until 7 January 2036 a preparation of endo-1,4-beta-xylanase and endo-1,3(4)-beta-glucanase from the genetically modified strains Komagataella phaffii DSM 25376 and DSM 26469 (ENZY CARBOPLUS, holder: Kaesler Nutrition GmbH) for hens, turkeys for breeding and minor poultry species, and in Regulation (EU) 2018/1090 lowers the minimum dose for chickens for fattening and reared for laying to 1400 LXU and 120 LGU/kg. EFSA (opinion of 18 March 2025) assigned the strains — formerly K. pastoris — to K. phaffii on the basis of genome sequences and found the additive safe and efficacious for all poultry; it is a respiratory sensitiser.

Source: Commission Implementing Regulation (EU) 2025/2556 of 17 December 2025 concerning the authorisation of a preparation of endo-1,4-beta-xylanase produced with Komagataella phaffii DSM 25376 and endo-1,3(4)-beta-glucanase produced with Komagataella phaffii DSM 26469 as a feed additive for chickens for laying or breeding, turkeys for breeding, minor poultry species for fattening and minor poultry species for laying or breeding (holder of authorisation: Kaesler Nutrition GmbH) and amending Implementing Regulation (EU) 2018/1090 as regards the terms of the authorisation of the preparation of endo-1,4-beta-xylanase produced with Komagataella phaffii DSM 25376 and endo-1,3(4)-beta-glucanase produced with Komagataella phaffii DSM 26469 as a feed additive for chickens for fattening and chickens reared for laying

Lab-News